Company Overview
Snapshot
Founded in April 2020 by Noam Levine, FIZE Medical is a Health Tech & Life Sciences company with 11–50 employees. The company has raised a total of $45.87 million across 7 funding rounds from 6 investors. In March 2026, FIZE Medical announced a $6 million warrant exercise, bringing its total Series A financing to $36 million.
Business overview
FIZE Medical develops platform technology for the remote monitoring and management of patients with indwelling Foley catheters. The company's core product, the FIZE kUO device, provides digital real-time measurement of kidney urine output and other key health indicators found in urine, coupled with customized alerts to support evidence-based clinical decision-making. Serving the healthcare industry, FIZE Medical operates within the Medical Devices and Digital Healthcare sectors, focusing on patient remote monitoring solutions for hospitals and doctors.
Strategic signal
FIZE Medical recently achieved a significant milestone by receiving CE mark and UKCA certification for its FIZE kUO System in July 2026. This regulatory approval enables the company to launch commercial operations across Europe and the UK, signaling a major expansion into international markets and validating the system's compliance with stringent European and British health, safety, and environmental protection standards. This move indicates a strong growth trajectory and potential for increased market penetration for its smart fluid management solutions.
Log in to access full profile ›Company Intelligence Q&A
- What was the most recent funding event for FIZE Medical?
- In March 2026, FIZE Medical announced a $6 million warrant exercise, bringing its total Series A financing to $36 million.
- When did FIZE Medical receive CE mark and UKCA certification for its FIZE kUO System?
- FIZE Medical received CE mark and UKCA certification for its FIZE kUO System in July 2026, enabling commercial operations across Europe and the UK.
- Has FIZE Medical expanded its distribution in Japan?
- In December 2025, FIZE Medical announced the launch of the FIZE kUO System in Japan under an exclusive distribution agreement with Asahi Kasei Medical.
- Which investors participated in FIZE Medical's Series A funding in December 2024?
- In December 2024, Rapha Capital Management led a Series A funding round for.
- What grant did FIZE Medical secure in February 2024?
- In February 2024, FIZE Medical secured a grant from the Israel Innovation Authority.